Background: Primary immunodeficiencies (PID) are a heterogeneous group of diseases that cause alterations in the immune system, leading to the increased susceptibility to infections, autoimmune diseases, and malignancies. The aim was to evaluate the presence of clinical manifestations and diagnoses of asthma, rhinitis, and atopic dermatitis in patients diagnosed with PID, and correlate these with allergen sensitization verified by skin prick testing (SPT). Material and Methods: This cross-sectional, descriptive, and observational study was conducted from February 2015 to February 2016. We performed a medical report analysis and SPT for aeroallergens in patients with a PID diagnosis. Results: Thirty-one patients with a PID diagnosis were included. The mean age of the participants was 15.41 years. From the 31 patients, 28 had symptoms suggestive of allergic disease (asthma, rhinitis, and atopic dermatitis) and only 7 presented positive SPT for at least 1 aeroallergen. Conclusion: The frequency of allergenic sensitization in the group of patients with PID and symptoms suggestive of asthma, rhinitis, or atopic dermatitis is lower than that found in the general population, probably due the impairment of IgE formation secondary to their immunologic alterations.

Keywords:
Primary immunodeficiencies, Allergy, Sensitization, Aeroallergens, Asthma, Rhinitis, Atopic dermatitis, Skin prick testing
1.
Picard C, Al-Herz W, Bousfiha A, et al: Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency, 2015. J Clin Immunol 2015; 35: 696–726.
2.
Rezaei N, Bonilla FA, Sullivan KE, de Vries E, Orange JS: An introduction to primary immunodeficiency diseases; in Rezaei N, Aghamohammadi A, and Notarangelo LD (eds): Primary Immunodeficiency Diseases, ed 5. Berlin, Springer, Germany 2008, pp 1–38.
3.
Boyle JM, Buckley RH: Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007; 27: 497–502.
4.
Lourenço DB, Munhoz DC, Bariani DB, et al: Prevalence of allergic rhinitis in IgA deficiency. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo 2012; 57: 63–66.
5.
Azizi G, Ahmadi M, Abolhassani H, et al: Autoimmunity in primary antibody deficiencies. Int Arch Allergy Immunol 2016; 171: 180–193.
6.
Soares FA, Segundo GR, Alves R, Ynoue LH: Indoor allergen sensitization profile in allergic patients of the allergy clinic in the University Hospital in Uberlândia, Brazil. Rev Assoc Med Bras 2007; 53: 25–28.
7.
Motta AA, Kalil J, Barros MT: Cutaneous tests. Rev Bras Alerg Imunopatol 2005; 28: 73–83.
8.
Asher MI, Keil U, Anderson HR, et al: International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483–491.
9.
Costa-Carvalho BT, Sano F, Rosario NA, Condino-Neto A, Solé R: Primary immunodeficiencies in the allergy practice in Brazil. Rev Bras Alerg Imunopatol 2011; 34: 241–250.
10.
Ramírez-Vargas N, Arablin-Oropeza SE, Mojica-Martínez D et al: Clinical and immunological features of common variable immunodeficiency in Mexican patients. Allergol Immunopathol (Madr) 2014; 42: 235–240.
11.
Leiva LE, Zelazco M, Oleastro M, et al: Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol 2007; 27: 101–108.
12.
Edgar JD, Buckland M, Guzman D, et al: The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol 2014; 175: 68–78.
13.
Özcan C, Metin A, Erkoçoğlu M, Kocabaş CN: Allergic diseases in children with primary immunodeficiencies. Turk J Pediatr 2014; 56: 41–47.
14.
Agondi RC, Barros MT, Kokron CM et al: Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy 2013; 27: 79–83.
15.
Kaneko K, Wang Z, Kim SH, Morelli AE, et al: Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection. Gene Ther 2003; 10: 143–512.
16.
Leite-de-Moraes MC, Dy M: Natural killer T cells: a potent cytokine-producing cell population. Eur Cytokine Netw 1997; 8: 229–237.
17.
Kwong CG, Bacharier LB: Microbes and the role of antibiotic treatment for wheezy lower respiratory tract illnesses in preschool children. Curr Allergy Asthma Rep 2017; 17: 34.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.